Publications

5532 Results

Clinical behavior of 2,168 patients treated on Southwest Oncology Group (SWOG) protocols and reclassified according to the REAL classification.

Authors
RI Fisher;TM Grogan;S Dahlberg;R Braziel;P Banks;B Nathwani;C Kjeldsberg;TP Miller
Journal / Conference
Annals of Oncology 7(Suppl.3):3(#006)
Year
1996
Research Committee(s)
Lymphoma

REAL classification of lymphoma allows improved delineation of histologic risk groups: A Southwest Oncology Group (SWOG) study.

Authors
TM Grogan;TP Miller;S Dahlberg;R Braziel;P Banks;B Nathwani;C Kjeldsberg;R Tubbs;RI Fisher
Journal / Conference
American Society of Clinical Oncology 15:425(1310)
Year
1996
Research Committee(s)
Lymphoma

Cytogenetics, MDR1, and disease status in elderly AML identify a subgroup with a high complete remission (CR) rate: A Southwest Oncology Group study.

Authors
ML Slovak;KJ Kopecky;T McConnell;CP Leith;J Godwin;IM Chen;C Rankin;DR Head;F Appelbaum;CL Willman
Journal / Conference
British Journal of Haematology 93(Suppl.2):134(#522)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9031

Randomized phase III trial of cisplatin (CDDP) vs. CDDP plus navelbine (NVB) in treatment of advanced non-small cell lung cancer (NSCLC): Report of a Southwest Oncology Group study (SWOG-9308).

Authors
AJ Wozniak;JJ Crowley;SP Balcerzak;GR Weiss;LR Laufman;LH Baker;RI Fisher;SI Bearman;SA Taylor;RB Livingston
Journal / Conference
American Society of Clinical Oncology 15:374(#111)
Year
1996
Research Committee(s)
Lung
Study Number(s)
SWOG-9308

Estrogen receptor methylation is a favorable prognostic factor in AML.

Authors
JJ Issa;KJ Kopecky;F Appelbaum;C Willman;SB Baylin
Journal / Conference
American Society of Clinical Oncology 15:357(#1048)
Year
1996
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8706

The prostate cancer prevention trial: Efforts to increase the recruitment of minority participants.

Authors
CM Moinpour
Journal / Conference
Poster for Conf on the Recruit and Retention of Min Parts in CCR 1/26-27/96 :
Year
1996
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

CHOP plus radiotherapy (RT) is superior to CHOP alone for adjuvant therapy of resected localized unfavorable non-Hodgkin's lymphoma (NHL).

Authors
TP Miller;S Dahlberg;JR Cassady;C Spier;TM Grogan;S Carlin;E Chase;RI Fisher
Journal / Conference
Proc 8th Intl Conf on the Adjuvant Therapy of Cancer :47(#27)
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8736 (INT-0093)

Infusional therapy with first generation chemosensitizers (CS) results in increased toxicity without improved benefit in untreated lymphoma.

Authors
ER Gaynor;TP Miller;S Dahlberg;M LeBlanc;RI Fisher
Journal / Conference
American Society of Clinical Oncology 15:413(#1265)
Year
1996
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-9125, SWOG-9240

Phase II trial of trimetrexate in advanced esophageal cancer: A Southwest Oncology Group study.

Authors
TR Fleming;TD Brown;SW Ross;JS Macdonald
Journal / Conference
Investigational New Drugs 13:363-365
Year
1996
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8721

Retrospective study of the correlation between the DNA repair protein alkyltransferase and survival of brain tumor patients treated wtih carmustine.

Authors
M Belanich;M Pastor;T Randall;D Guerra;J Kibitel;L Alas;B Li;M Citron;P Wasserman;A White;H Eyre;K Jaeckle;S Schulman;D Rector;M Prados;S Coons;W Shapiro;D Yarosh
Journal / Conference
Cancer Research 56(4):783-788
Year
1996
Research Committee(s)
Brain
Study Number(s)
SWOG-9218